ENGOT-OV16/NOVA

2:38
NOVA Phase III trial of niraparib in platinum-sensitive ovarian cancer patients
Nicoletta Colombo
1:50
Niraparib as maintenance for platinum-sensitive ovarian cancer – results from ENGOT-OV16/NOVA trial
Sven Mahner
1:13
Comparison of trials of niraparib, olaparib and rucaparib in ovarian cancer
Mansoor Mirza
2:26
Trial design of ENGOT-OV16/NOVA Phase III trial of niraparib in platinum-sensitive ovarian cancer
Mansoor Mirza
3:09
The promising potential of PARP inhibitors in ovarian cancer
Jonathan Ledermann
3:10
Overview of ENGOT-OV16/NOVA of niraparib in ovarian cancer and why the results were not surprising
Ursula Matulonis
1:14
Next steps for niraparib for ovarian cancer following on from the ENGOT-OV16/NOVA trial
Sven Mahner
The content of VJOncology is intended for healthcare professionals